Mφ1 and Mφ2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals

被引:150
作者
Gratchev, Alexei [1 ]
Kzhyshkowska, Julia [1 ]
Koethe, Kirsten [1 ]
Muller-Molinet, Isabelle [1 ]
Kannookadan, Sheila [1 ]
Utikal, Jochen [1 ]
Goerdt, Sergij [1 ]
机构
[1] Heidelberg Univ, Dept Dermatol, Med Ctr, D-6800 Mannheim, Germany
关键词
cytokines; human; inflammation; lipopolysaccharide; monocytes/macrophages;
D O I
10.1016/j.imbio.2006.05.017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Macrophages (M phi) represent a dynamic cell population that develops and operates within a changing microenvironment. in parallel to Th1/Th2 cells, primary M phi may undergo classical (M phi 1) or alternative (M phi 2) activation. Here, we investigated whether M phi 1/M phi 2 may be re-polarized by a secondary stimulation by Th1 or Th2 cytokines or by exogenous danger signals. We established that M phi 1(IFN gamma) respond to alternative activation by IL-4 and IL-10 by de novo secretion of Th2 cytokines AMAC-1 and IL-1ra, and by an increase in phagocytic capacity and a decrease in bactericidal activity. Vice versa, M phi 2 responded to classical activation by IFN gamma exhibiting reduced phagocytosis and significantly increased bacterial killing while being refractory regarding secretion of TNF alpha, IL-1 beta and IL-12. In response to the bacterial danger signals LPS and MDP, both M phi 1 and M phi 2 produced IL-1 beta and TNF alpha; in addition M phi 2 expressed the Th1-inducing cytokine IL-12. The ability of M phi to be re-polarized and to react to exogenous danger signals is a precondition to down-regulate an outdated immune reaction and to retain the capacity to mount an adequate anti-bacterial response. Selective refractoriness of M phi 1 and M phi 2 to IFN gamma- and LPS-induced cytokine secretion may contribute to prevent autoimmunity. (c) 2006 Elsevier GmbH. All rights reserved.
引用
收藏
页码:473 / 486
页数:14
相关论文
共 37 条
  • [1] IL-12: The role of p40 versus p75
    Abdi, K
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 56 (01) : 1 - 11
  • [2] Cutting edge:: Biasing immune responses by directing antigen to macrophage Fcγ receptors
    Anderson, CF
    Mosser, DM
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (08) : 3697 - 3701
  • [3] GLUCOCORTICOIDS SUPPRESS INTERLEUKIN-1 RECEPTOR ANTAGONIST SYNTHESIS FOLLOWING INDUCTION BY ENDOTOXIN
    ARZT, E
    SAUER, J
    POLLMACHER, T
    LABEUR, M
    HOLSBOER, F
    REUL, JMHM
    STALLA, GK
    [J]. ENDOCRINOLOGY, 1994, 134 (02) : 672 - 677
  • [4] MACROPHAGE DEACTIVATION BY INTERLEUKIN-10
    BOGDAN, C
    VODOVOTZ, Y
    NATHAN, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) : 1549 - 1555
  • [5] ALPHA-1-ACID GLYCOPROTEIN POTENTIATES LIPOPOLYSACCHARIDE-INDUCED SECRETION OF INTERLEUKIN-1-BETA, INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA BY HUMAN MONOCYTES AND ALVEOLAR AND PERITONEAL-MACROPHAGES
    BOUTTEN, A
    DEHOUX, M
    DESCHENES, M
    ROUZEAU, JD
    BORIES, PN
    DURAND, G
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (10) : 2687 - 2695
  • [6] Suppression of IL-12 transcription in macrophages following Fcγ receptor ligation
    Cappiello, MG
    Sutterwala, FS
    Trinchieri, G
    Mosser, DM
    Ma, XJ
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (07) : 4498 - 4506
  • [7] STIMULATORY AND INHIBITORY EFFECTS OF INTERLEUKIN (IL)-4 AND IL-13 ON THE PRODUCTION OF CYTOKINES BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - PRIMING FOR IL-12 AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION
    DANDREA, A
    MA, XJ
    ASTEAMEZAGA, M
    PAGANIN, C
    TRINCHIERI, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) : 537 - 546
  • [8] Reversing lipopolysaccharide toxicity by ligating the macrophage Fcγ receptors
    Gerber, JS
    Mosser, DM
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (11) : 6861 - 6868
  • [9] Other functions, other genes: Alternative activation of antigen-presenting cells
    Goerdt, S
    Orfanos, CE
    [J]. IMMUNITY, 1999, 10 (02) : 137 - 142
  • [10] Alternative activation of macrophages
    Gordon, S
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (01) : 23 - 35